Expanding Health Flexible Spending Accounts to Reimburse Over-the-Counter Drugs: A Positive Move by Cancelosi, Susan E.
Wayne State University
Law Faculty Research Publications Law School
1-1-2003
Expanding Health Flexible Spending Accounts to
Reimburse Over-the-Counter Drugs: A Positive
Move
Susan E. Cancelosi
University of Houston, scancelosi@wayne.edu
This Article is brought to you for free and open access by the Law School at DigitalCommons@WayneState. It has been accepted for inclusion in Law
Faculty Research Publications by an authorized administrator of DigitalCommons@WayneState.
Recommended Citation
Susan E. Cancelosi, Expanding Health Flexible Spending Accounts to Reimburse Over-the-Counter Drugs: A Positive Move, Health L. Persp.
(2003).
Available at: https://digitalcommons.wayne.edu/lawfrp/224
Expanding Health Flexible Spending Accounts to Reimburse Over-the-Counter Drugs: A Positive Move
Susan E. Cancelosi, J.D., LL.M. Candidate
With the Medicare prescription drug coverage debate raging in Congress, national attention is riveted on just how much
drugs cost.  Prescription drugs often take center stage, but by some estimates more than 60 percent of the drugs bought
each year are sold over-the-counter.  (Devon M. Herrick, Brief Analysis No. 448, National Center for Policy Analysis
(July 24, 2003), available at http://www.ncpa.org.)  Recognizing this trend, the Treasury Department and the Internal
Revenue Service in September reversed a long-held position that had previously barred tax-free reimbursement of
nonprescription drugs from employer-sponsored health care flexible spending accounts (“health FSAs”).  Beginning in
2003, employees may be reimbursed by their health FSAs for over-the-counter drug purchases.  (Rev. Rul. 2003-102,
2003-38 I.R.B. 559 (Sept. 22, 2003).)
A health FSA is an employer-sponsored benefit plan that allows employees to set aside part of their pay on a pre-tax basis
to apply toward health care expenses that are not covered by insurance or otherwise paid by the employer.  As long as the
reimbursed expenses qualify as expenses for the medical care of the employee, the employee’s spouse or the employee’s
dependents, the Internal Revenue Code (the “Code”) excludes the reimbursements from the employee’s taxable income. 
(I.R.C. Section 105(b).)  “Medical care” for these purposes means medical care as defined in Code Section 213(d), which
includes “amounts paid … for the diagnosis, cure, mitigation, treatment, or prevention of disease, or for the purpose of
affecting any structure or function of the body.”  (I.R.C. Section 213(d)(1)(A).)  Despite the broad wording of Code
Section 213(d), the IRS has held specifically that “[a]mounts paid by an individual for medicines or drugs that may be
purchased without a prescription of a physician are not … deductible under [Code Section] 213.”  (Rev. Rul. 2003-58,
2003-22 I.R.B. 959 (June 2, 2003).)  Before the IRS announcement in September, Code Section 105(b)’s specific reference
to Code Section 213(d) had consistently been interpreted to mean that health FSAs could reimburse on a tax-free basis
only those medical expenses that could be deducted under Code Section 213.
In announcing the new interpretation of Code Section 105(b), the Treasury Department and the IRS focused on recent
trends in the pharmaceutical industry.  “Since many prescription drugs have moved to the over-the-counter market, this
action today makes paying for them a little bit easier to swallow,” said Treasury Secretary John Snow in the press release
announcing the change, available at http://www.ustreas.gov/press/releases/js695.htm. On a technical level, the government
reached its new position by focusing on the absence of any express requirement in Code Section 105(b) that reimbursable
expenses must also qualify as deductible expenses under Code Section 213.  The government also noted that Code Section
105(b) does not prohibit reimbursement of nonprescription drugs.  Rev. Rul. 2003-102 does, however, emphasize that
reimbursable over-the-counter drugs and medicines must be for medical care, not “merely beneficial to the general health”
of the employee, the employee’s spouse or the employee’s dependents.  Following this approach, dietary supplements are
expressly excluded from tax-free reimbursement.
Employers are not required to change the terms of their health FSAs to reimburse nonprescription drugs.  Early surveys,
however, suggest that most large companies will adopt the more generous rules beginning in 2004.  (Washington Business
Group on Health Survey (Oct. 1, 2003), available at http://www.wbgh.com). 
 As with most new regulatory actions, questions remain.  The IRS in Rev. Rul. 2003-102 addressed specifically only
antacids, allergy medicines, pain relievers, cold medicines and vitamins.  But what about dual purpose items that may be
beneficial to general health as well as having a medical purpose?  Examples include baby aspirin taken by adults as a
preventative measure, lactose intolerance aids, and herbal medicines.  Employers must establish clear policies to inform
employees what will and will not be reimbursed, but they must do so without the benefit of any detailed guidance from the
IRS.  What kind of documentation should employers require?  Presumably receipts clearly indicating what was purchased
will suffice, but again the IRS has not provided specific guidelines.
Finally, is this a positive step by the government?  For employees who need drugs that were previously available only by
prescription and typically covered under an employer’s prescription drug plan, the overall trend toward over-the-counter
drugs has created frustration and, in some cases, financial hardship.  Although over-the-counter drugs may be much less
expensive than prescription drugs in general, they still may be more expensive than the low co-payment an employee was
comfortable paying.  Extending health FSA coverage to nonprescription drugs at least mitigates the increased financial
burden on such employees.  For employers struggling to maintain health insurance for their employees, this expansion of
the health FSA rules costs nothing for the employers to add but gives employees a true benefit.  It is a rare government
move that has such an overall positive impact.
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